Literature DB >> 19040618

The effect of myoma uteri and myomectomy on sexual function.

Devrim Ertunc1, Roza Uzun2, Ekrem C Tok2, Arzu Doruk2, Saffet Dilek2.   

Abstract

INTRODUCTION: This is a report about the effects of myoma uteri and myomectomy on sexual function in women. AIM: The aim of this article was to determine the effects of myoma uteri and myomectomy on sexual function in women.
METHOD: The study was designed as a controlled clinical study in an academic clinical research center. The study patients consisted of 80 women with myoma uteri and 75 control women. Baseline characteristics and properties of the myomas were recorded. A validated questionnaire was used to determine pre- and postoperative sexual function in the patients. MAIN OUTCOME MEASURE: Female sexual function index (FSFI) scores of the women were recorded before and after surgery.
RESULTS: Women with myoma uteri had lower FSFI pain and satisfaction scores than women without it, even after correction for possible confounders. Fundal and posterior myomas were associated with pain, whereas only posterior myomas were related to the overall FSFI scores. However, although there was no relation between the volume of the myomas and the FSFI scores, women with a uterine volume over 200 cm(3) had significantly lower mean FSFI satisfaction, pain, and total scores. The mean FSFI pain and total scores of the patients improved significantly after undergoing a myomectomy.
CONCLUSIONS: The findings of this study suggest that a potential impairment of sexual function exists in women with myomas. This is mainly because of pain during sexual intercourse, although it does not seem to have an effect on either the arousal or orgasmic phases. Furthermore, the performance of a myomectomy may alleviate pain during intercourse, and thereby improve sexual function in the patients.

Entities:  

Mesh:

Year:  2008        PMID: 19040618     DOI: 10.1111/j.1743-6109.2008.01086.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  7 in total

1.  Effect of menses on standardized assessment of sexual dysfunction among women with uterine fibroids: a cohort study.

Authors:  Shannon K Laughlin-Tommaso; Bijan J Borah; Elizabeth A Stewart
Journal:  Fertil Steril       Date:  2015-05-16       Impact factor: 7.329

2.  Efficacy of high-intensity focused ultrasound ablation for adenomyosis therapy and sexual life quality.

Authors:  Ling Long; Jinyun Chen; Yu Xiong; Min Zou; Yongbin Deng; Li Chen; Zhibiao Wang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.

Authors:  Anne Zimmermann; David Bernuit; Christoph Gerlinger; Matthias Schaefers; Katharina Geppert
Journal:  BMC Womens Health       Date:  2012-03-26       Impact factor: 2.809

4.  Female Sexual Dysfunction in Women with Non-Malignant Cervical Diseases: A Study from an Urban Chinese Sample.

Authors:  Jiehua Ma; Yanjing Kan; Aixia Zhang; Yu Lei; Bin Yang; Ping Li; Lianjun Pan
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

5.  Postoperative Quality of Life and Sexual Function in Premenopausal Women Undergoing Laparoscopic Myomectomy for Symptomatic Fibroids: A Prospective Observational Cohort Study.

Authors:  Julia Caroline Radosa; Christoph Georg Radosa; Russalina Mavrova; Stefan Wagenpfeil; Amr Hamza; Ralf Joukhadar; Sascha Baum; Maria Karsten; Ingolf Juhasz-Boess; Erich-Franz Solomayer; Marc Philipp Radosa
Journal:  PLoS One       Date:  2016-11-29       Impact factor: 3.240

6.  Symptoms and Health Quality After Laparoscopic and Robotic Myomectomy.

Authors:  Ozguc Takmaz; Esra Ozbasli; Savas Gundogan; Ercan Bastu; Cem Batukan; Suat Dede; Mete Gungor
Journal:  JSLS       Date:  2018 Oct-Dec       Impact factor: 2.172

7.  Comparison of Sexual Dysfunction Using the Female Sexual Function Index following Surgical Treatments for Uterine Fibroids.

Authors:  Allison Ryann Louie; Jennifer Alice Armstrong; Laura Katherine Findeiss; Scott Craig Goodwin
Journal:  Case Rep Obstet Gynecol       Date:  2012-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.